Skip to content
Home/Companies/HealthTech/Bioscript
Bioscript

Bioscript

HealthTech·UK·Active·5yr hold
Entry
2021
Hold
5yr
Status
Active

Who owns Bioscript?

Bioscript is currently owned by Sovereign Capital through Sovereign Capital IV (2014 vintage), since 2021.

Hand-verified · updated 2026-06-30

Sovereign Capital
Investor
Sovereign Capital
Sovereign Capital IV · 2014 · Small-Mid Buyout

Key facts

HQUK
SectorHealthTech
StatusActive
Websitebioscriptgroup.com

More from Sovereign Capital IV

Other portfolio companies in the same fund.

Data Intellect
Data Intellect
Active
Data & AnalyticsUK· 2021
Eden Futures
Eden Futures
Active
HealthcareUK· 2021
Acolin
Acolin
Exited 2025
FintechSwitzerland· 2019
to
Agena Group
Agena Group
Exited 2025
Business ServicesUK· 2019
to
Utility Bidder
Utility Bidder
Exited 2026
Business ServicesUK· 2018
to

More PE-backed in HealthTech

Comparable healthtech deals from other GPs.

52North Health
52North Health
Active
Future Planet CapitalUK
A Place for Mom
A Place for Mom
Active
Silver LakeUS
Advance Medical
Active
Summit PartnersUS
AdvancedMD
AdvancedMD
Active
Francisco PartnersUS
agilon health
agilon health
Active
CD&RUS
Akrivia Health
Akrivia Health
Active
Future Planet CapitalUK
Track Bioscript

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Bioscript?

5 strategic and 115financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Bioscript.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue